Evidence for association of SNPs inABCB1andCBR3, but notRAC2, NCF4, SLC28A3orTOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines
出版年份 2016 全文链接
标题
Evidence for association of SNPs inABCB1andCBR3, but notRAC2, NCF4, SLC28A3orTOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 17, Issue 3, Pages 231-240
出版商
Future Medicine Ltd
发表日期
2016-01-23
DOI
10.2217/pgs.15.162
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer
- (2015) Megan E. V. Caram et al. BREAST CANCER RESEARCH AND TREATMENT
- Individual Prediction of Heart Failure Among Childhood Cancer Survivors
- (2015) Eric J. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
- (2015) Folefac Aminkeng et al. NATURE GENETICS
- Genetic variants inSLC22A17 and SLC22A7are associated with anthracycline-induced cardiotoxicity in children
- (2015) Henk Visscher et al. PHARMACOGENOMICS
- Using Pharmacogene Polymorphism Panels to Detect Germline Pharmacodynamic Markers in Oncology
- (2014) D. L. Hertz et al. CLINICAL CANCER RESEARCH
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity
- (2013) Daniel L Hertz et al. JOURNAL OF HUMAN GENETICS
- Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children
- (2013) H. Visscher et al. PEDIATRIC BLOOD & CANCER
- Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients
- (2012) Pei Jye Voon et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Decline in the Use of Anthracyclines for Breast Cancer
- (2012) Sharon H. Giordano et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
- (2011) Heloisa Sawaya et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity
- (2010) Lu Fan et al. Pharmacogenetics and Genomics
- Naturally Occurring Variants of Human CBR3 Alter Anthracycline In Vitro Metabolism
- (2009) O. S. Bains et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
- (2009) D Rossi et al. LEUKEMIA
- Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients
- (2009) J M Rae et al. PHARMACOGENOMICS JOURNAL
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897
- (2008) Patricia A. Ganz et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now